🇺🇸 FDA
Patent

US 6051230

Compositions for targeting the vasculature of solid tumors

expired A61KA61K2039/505A61K2123/00

Quick answer

US patent 6051230 (Compositions for targeting the vasculature of solid tumors) held by The Board of Regents of the University of Texas System expires Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Apr 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
61
CPC classes
A61K, A61K2039/505, A61K2123/00, A61K38/00, A61K47/6817